Between February 2020 and August 2022, the Company executed four grant agreements (the "Grants") with the Michael J. Fox Foundation for the purpose of researching Parkinson's disease.
MapLight Therapeutics, Inc. Customers
No clients on recordNo downstream customers found in our database for MapLight Therapeutics, Inc..
MapLight Therapeutics, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
MPLT-DEBT-17123
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2025-12-31.
MPLT-DEBT
Debt stack $5.6M
90%
Market cache reports total debt of $5.6M.
MapLight Therapeutics, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for MapLight Therapeutics, Inc..
MapLight Therapeutics, Inc. Ownership
Holder
Name
Confidence
Evidence
MPLT-OWNER-GOLDMAN-SACHS-GROUP-INC
GOLDMAN SACHS GROUP INC
90%
13F overlay lists GOLDMAN SACHS GROUP INC as top holder; 81 tracked holders.
MapLight Therapeutics, Inc. Extended Supply Chain Network